🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

359 results for “vaccine” Clear

  1. CSL Limited Influenza Vaccine

    Seqirus (Australia) Pty Ltd

    Influenza

    approved mab completed

    1 trial

  2. Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine

    Sinovac Research and Development Co.,

    Influenza and Pneumonia

    approved mab completed

    1 trial

  3. Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    The George Institute

    Covid-19 infection

    approved small molecule active

    1 trial

  4. Concomitant administration of EV71 vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  5. Concomitant administration of EV71vaccine with EPI vaccines

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  6. Covid-19 vaccine (0-1-4 schedule)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    approved mab active

    2 trials

  7. EV71 Vaccine

    Sinovac Research and Development Co.,

    EV71 Vaccine

    approved mab completed

    1 trial

  8. EV71 Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  9. EV71 inactived vaccine（Vero cells）

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  10. EV71 vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab completed

    1 trial

  11. Egg based influenza vaccines

    BRIGHT MINDS BIOSCIENCES INC.

    Influenza

    approved mab active

    1 trial

  12. Experimental Vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  13. Experimental vaccine 1

    Sinovac Research and Development Co.,

    COVID-19

    approved mab on hold

    1 trial

  14. Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva

    The George Institute

    Avian influenza and seasonal influenza

    approved small molecule active

    1 trial

  15. Fluenz nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    Influenza

    approved small molecule active

    1 trial

  16. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  17. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre Fabre Australia Pty Ltd

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  18. H1N1 influenza A Vaccine (PANFLU.1)

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  19. H1N1 influenza A Vaccine (Split virion), Inactivated

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  20. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial

  21. High-dosage SARS-CoV-2 vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    1 trial

  22. High-dosage of COVID-19 vaccine (Vero cell), Inactivated

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  23. Inactivated COVID-19 vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19

    approved mab active

    1 trial

  24. Inactivated HAV vaccine

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources